Effect of PNF stretching and chest mobility exercises in Covid-19 survivors
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J984- Other disorders of lung
- Registration Number
- CTRI/2021/08/035492
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Post Covid patients with mild and moderate recovery-
Asymptomatic
Does not need oxygen support on exercise or activity
MMRC dyspnea grade <2
Subjects who are independent in mobility
Subjects willing to participate.Ã?Â
Duration : 6-8 months after recovery
Baseline values for chest expansion:
Upper thoracic: male- 2.6+1.4cm
female- 2.2+1.2cm
Lower thoracic: male- 2.3+1.1.2cm
female- 1.7+1.1cm
Any musculoskeletal disorders affecting upper limb.
Any pathological condition affecting muscle, joint and bone Such as rheumatoid arthritis, severe osteoporosis.
Cardiovascular dysfunction (eg, ischemic heart disease, uncontrolled hypertension)
Additional conditions restricting chest expansion. (eg, obesity, severe scoliosis, ankylosing spondylitis)
Recent chest or abdominal surgery.
Pathology of spine such as disc protrusion, spondylolisthesis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary Function-SpirometryTimepoint: 7 sessions/1week. <br/ ><br>pulmonary function will be assesed with spirometry on the first session and after the last session.
- Secondary Outcome Measures
Name Time Method Chest Expansion-Inch TapeTimepoint: It will be assessed before the first session on day1 and after the last session on day7.;FatigueTimepoint: VAS for fatigue